Jun Kang

805 citations
36 papers · 593 indexed · h-index 13
Topics
Pituitary Gland Disorders and Treatments (9 papers)Glioma Diagnosis and Treatment (8 papers)Meningioma and schwannoma management (6 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Jun Kang

34 papers receiving 587 citations

Peers

Jun Kang
Comparison fields: 5 of 72
  • Endocrinology, Diabetes and Metabolism 184
  • Epidemiology 142
  • Surgery 131
  • Molecular Biology 131
  • Cancer Research 124
Replace Chu-Feng Liu with:
Chu-Feng Liu Taiwan
Seung‐Hun Oh South Korea
Takuji Watanabe Japan
Naofumi Oyamada Japan
Shingo Minatoguchi Japan
Brandon Liebelt United States
K.W. Annie Bang Canada
Lin Fan China
Wenqiang Xin China
Yasuhiro Takeshima Japan
Jun Kang relative to Chu-Feng Liu Taiwan Chu-Feng Liu's profile →
Citations per field
00.5×1.5×2.4×
Chu-Feng Liu · 1×
Citations per year

Countries citing papers authored by Jun Kang

Since Specialization
Citations

This map shows the geographic impact of Jun Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Kang more than expected).

Fields of papers citing papers by Jun Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Kang. The network helps show where Jun Kang may publish in the future.

Co-authorship network of co-authors of Jun Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Kang. A scholar is included among the top collaborators of Jun Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Kang. Jun Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 8
3 6
4 4
5 1
6 10
7 20
8 4
9 7
10 4
11 20
12 1
13 41
14 6
15 14
16 7
17 12
18 25
19 70
20
[Separation of human bladder cancer cells from bone marrow with a kind of immunomagnetic microspheres].
1

About Jun Kang

Jun Kang is a scholar working on Genetics, Neurology and Ophthalmology, having authored 36 papers that have together received 593 indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (9 papers), Glioma Diagnosis and Treatment (8 papers) and Meningioma and schwannoma management (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (184 citations), Developmental Neuroscience (39 citations) and Genetics (89 citations). Jun Kang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Congxin Dai, Bowen Sun, Shangfeng Zhao, Renzhi Wang, Yumin Luo, Xunming Ji, Haiping Zhao, Feng Yan, Siyu Liang and Yong Yao. Their work appears in journals such as Stroke, Journal of neurosurgery and British Journal of Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026